Improved Molecular Diagnosis of McCune–Albright Syndrome and Bone Fibrous Dysplasia by Digital PCR

Francesca Marta Elli, Luisa de Sanctis, Massimiliano Bergallo, Maria Antonia Maffini, Arianna Pirelli, Ilaria Galliano, Paolo Bordogna, Maura Arosio, Giovanna Mantovani

Research output: Contribution to journalArticle

Abstract

McCune–Albright syndrome (MAS) is a rare congenital disorder characterized by the association of endocrine and nonendocrine anomalies caused by somatic activating variants of GNAS. The mosaic state of variants makes the clinical presentation extremely heterogeneous depending on involved tissues. Biological samples bearing a low level of mosaicism frequently lead to false-negative results with an underestimation of causative molecular alterations, and the analysis of biopsies is often needed to obtain a molecular diagnosis. To date, no reliable analytical method for the noninvasive testing of blood is available. This study was aimed at validating a novel and highly sensitive technique, the digital PCR (dPCR), to increase the detection rate of GNAS alterations in patients with a clinical suspicion of MAS and, in particular, in blood. We screened different tissues (blood, bone, cutis, ovary, and ovarian cyst) collected from 54 MAS patients by different technical approaches. Considering blood, Sanger was unable to detect mutations, the allele-specific PCR and the co-amplification at lower denaturation temperature had a 9.1% and 18.1% detection rate, respectively, whereas the dPCR reached a 37.8% detection rate. In conclusion, the dPCR resulted in a cost-effective, reliable, and rapid method allowing the selective amplification of low-frequency variants and able to improve GNAS mutant allele detection, especially in the blood.

Original languageEnglish
Article number862
JournalFrontiers in Genetics
Volume10
DOIs
Publication statusPublished - Sep 18 2019

Fingerprint

Fibrous Dysplasia of Bone
Polymerase Chain Reaction
Alleles
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Ovarian Cysts
Mosaicism
Ovary
Biopsy
Costs and Cost Analysis
Bone and Bones
Mutation
Temperature

Keywords

  • bone fibrous dysplasia
  • digital PCR
  • GNAS
  • McCune–Albright’s syndrome
  • mosaicism
  • precocious puberty

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Genetics(clinical)

Cite this

Improved Molecular Diagnosis of McCune–Albright Syndrome and Bone Fibrous Dysplasia by Digital PCR. / Elli, Francesca Marta; de Sanctis, Luisa; Bergallo, Massimiliano; Maffini, Maria Antonia; Pirelli, Arianna; Galliano, Ilaria; Bordogna, Paolo; Arosio, Maura; Mantovani, Giovanna.

In: Frontiers in Genetics, Vol. 10, 862, 18.09.2019.

Research output: Contribution to journalArticle

Elli, Francesca Marta ; de Sanctis, Luisa ; Bergallo, Massimiliano ; Maffini, Maria Antonia ; Pirelli, Arianna ; Galliano, Ilaria ; Bordogna, Paolo ; Arosio, Maura ; Mantovani, Giovanna. / Improved Molecular Diagnosis of McCune–Albright Syndrome and Bone Fibrous Dysplasia by Digital PCR. In: Frontiers in Genetics. 2019 ; Vol. 10.
@article{c366ec23a12946a499436b5191e00abe,
title = "Improved Molecular Diagnosis of McCune–Albright Syndrome and Bone Fibrous Dysplasia by Digital PCR",
abstract = "McCune–Albright syndrome (MAS) is a rare congenital disorder characterized by the association of endocrine and nonendocrine anomalies caused by somatic activating variants of GNAS. The mosaic state of variants makes the clinical presentation extremely heterogeneous depending on involved tissues. Biological samples bearing a low level of mosaicism frequently lead to false-negative results with an underestimation of causative molecular alterations, and the analysis of biopsies is often needed to obtain a molecular diagnosis. To date, no reliable analytical method for the noninvasive testing of blood is available. This study was aimed at validating a novel and highly sensitive technique, the digital PCR (dPCR), to increase the detection rate of GNAS alterations in patients with a clinical suspicion of MAS and, in particular, in blood. We screened different tissues (blood, bone, cutis, ovary, and ovarian cyst) collected from 54 MAS patients by different technical approaches. Considering blood, Sanger was unable to detect mutations, the allele-specific PCR and the co-amplification at lower denaturation temperature had a 9.1{\%} and 18.1{\%} detection rate, respectively, whereas the dPCR reached a 37.8{\%} detection rate. In conclusion, the dPCR resulted in a cost-effective, reliable, and rapid method allowing the selective amplification of low-frequency variants and able to improve GNAS mutant allele detection, especially in the blood.",
keywords = "bone fibrous dysplasia, digital PCR, GNAS, McCune–Albright’s syndrome, mosaicism, precocious puberty",
author = "Elli, {Francesca Marta} and {de Sanctis}, Luisa and Massimiliano Bergallo and Maffini, {Maria Antonia} and Arianna Pirelli and Ilaria Galliano and Paolo Bordogna and Maura Arosio and Giovanna Mantovani",
year = "2019",
month = "9",
day = "18",
doi = "10.3389/fgene.2019.00862",
language = "English",
volume = "10",
journal = "Frontiers in Genetics",
issn = "1664-8021",
publisher = "Frontiers Media S. A.",

}

TY - JOUR

T1 - Improved Molecular Diagnosis of McCune–Albright Syndrome and Bone Fibrous Dysplasia by Digital PCR

AU - Elli, Francesca Marta

AU - de Sanctis, Luisa

AU - Bergallo, Massimiliano

AU - Maffini, Maria Antonia

AU - Pirelli, Arianna

AU - Galliano, Ilaria

AU - Bordogna, Paolo

AU - Arosio, Maura

AU - Mantovani, Giovanna

PY - 2019/9/18

Y1 - 2019/9/18

N2 - McCune–Albright syndrome (MAS) is a rare congenital disorder characterized by the association of endocrine and nonendocrine anomalies caused by somatic activating variants of GNAS. The mosaic state of variants makes the clinical presentation extremely heterogeneous depending on involved tissues. Biological samples bearing a low level of mosaicism frequently lead to false-negative results with an underestimation of causative molecular alterations, and the analysis of biopsies is often needed to obtain a molecular diagnosis. To date, no reliable analytical method for the noninvasive testing of blood is available. This study was aimed at validating a novel and highly sensitive technique, the digital PCR (dPCR), to increase the detection rate of GNAS alterations in patients with a clinical suspicion of MAS and, in particular, in blood. We screened different tissues (blood, bone, cutis, ovary, and ovarian cyst) collected from 54 MAS patients by different technical approaches. Considering blood, Sanger was unable to detect mutations, the allele-specific PCR and the co-amplification at lower denaturation temperature had a 9.1% and 18.1% detection rate, respectively, whereas the dPCR reached a 37.8% detection rate. In conclusion, the dPCR resulted in a cost-effective, reliable, and rapid method allowing the selective amplification of low-frequency variants and able to improve GNAS mutant allele detection, especially in the blood.

AB - McCune–Albright syndrome (MAS) is a rare congenital disorder characterized by the association of endocrine and nonendocrine anomalies caused by somatic activating variants of GNAS. The mosaic state of variants makes the clinical presentation extremely heterogeneous depending on involved tissues. Biological samples bearing a low level of mosaicism frequently lead to false-negative results with an underestimation of causative molecular alterations, and the analysis of biopsies is often needed to obtain a molecular diagnosis. To date, no reliable analytical method for the noninvasive testing of blood is available. This study was aimed at validating a novel and highly sensitive technique, the digital PCR (dPCR), to increase the detection rate of GNAS alterations in patients with a clinical suspicion of MAS and, in particular, in blood. We screened different tissues (blood, bone, cutis, ovary, and ovarian cyst) collected from 54 MAS patients by different technical approaches. Considering blood, Sanger was unable to detect mutations, the allele-specific PCR and the co-amplification at lower denaturation temperature had a 9.1% and 18.1% detection rate, respectively, whereas the dPCR reached a 37.8% detection rate. In conclusion, the dPCR resulted in a cost-effective, reliable, and rapid method allowing the selective amplification of low-frequency variants and able to improve GNAS mutant allele detection, especially in the blood.

KW - bone fibrous dysplasia

KW - digital PCR

KW - GNAS

KW - McCune–Albright’s syndrome

KW - mosaicism

KW - precocious puberty

UR - http://www.scopus.com/inward/record.url?scp=85072888738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072888738&partnerID=8YFLogxK

U2 - 10.3389/fgene.2019.00862

DO - 10.3389/fgene.2019.00862

M3 - Article

AN - SCOPUS:85072888738

VL - 10

JO - Frontiers in Genetics

JF - Frontiers in Genetics

SN - 1664-8021

M1 - 862

ER -